Brain Disorders & Therapy

Characterization of micro particles derived from cultured macrophages and cerebrospinal fluid of patients with schizophrenic and affective disorders

International Conference on Brain Disorders & Therapeutics

August 24-26, 2015 London, UK

E Marion Schneider1, Haouraa Mostafa, Fabian Zink, Karl Bechter, Maximillian Strunz and Robert Loewe

Universitatsklinikum Ulm, Germany
Bezirkskrankenhaus Guenzburg, Germany
Genewake GmbH, Germany

Scientific Tracks Abstracts: Brain Disord Ther

Abstract:

Inflammatory antigen presenting cells (APC, dendritic cells and macrophages) are characteristic for patients with affective disorders and can be enriched from Ficoll-isolated mononuclear cells by 3-4 weeks of in vitro culture. Flow cytometry, electron microscopy, Western Blots and cytokine quantification were applied to characterize the cell type and the inflammatory response in blood and cerebrospinal fluid (CSF). These analyses demonstrate that the enriched APC can be classified into either dendritic cells (iDCs) or M1 or M2 macrophages. All cell isolates display high macropinocytotic activity and in addition form prominent autophagous vacuoles. The M1 type occurred more often in affective disorders than in schizophrenics. M1 cells expressed the ATP-sensitive P2R7 ion channel. ATP stimulation of the P2X7 ion channel caused the release of plasma membrane vesicles and microparticles (MP). MPs enriched from blood-derived APC cultures and from native CSF were subjected to protein chemical as well as miRNA analysis. All MP preparations were �²-actin positive and in part stained for the autophagy marker LC3-II. When compared to the cultured APC-target cells, the microparticles were stronger positive for arginase 1, CD95, S100 and CD178 whereas CD36 and the TNF-R type I (CD120a) were decreased. MiRNA analysis revealed inflammatory signatures in the majority of affective disorders. These results indicate that microparticles may transport protein and miRNA species to target tissues. The current protocol proved to be valid to simultaneously study MP generation in vitro using cultured APC and to isolate and characterize MP from the CSF.

Biography :

E Marion Schneider has completed her PhD with honors from the University of Bonn, Germany and Post-doctoral studies from Institute Pasteur, France. She finalized her habilitation in 1988 on Immunology and teaches in Immunology in a variety of inflammatory diseases including SIRS, sepsis and neuroinflammation. She leads the section on Experimental Anesthesiology in Ulm, Germany since 1997. She has published more than 250 original manuscripts and provides ample experience on biomarkers in various diseases and signaling. Her current focus is on in vivo activated antigen presenting cells.

Email: marion.schneider@uni-ulm.de